Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer

NCT04257448 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer
Pancreatic Adenocarcinoma
Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: Romidepsin
DRUG: Azacitidine
DRUG: nab-Paclitaxel
DRUG: Gemcitabine
DRUG: Durvalumab
DRUG: Lenalidomide capsule

Sponsor

GWT-TUD GmbH

Collaborators

[object Object]
[object Object]